ArticleiLIVER2026
Global trends, health inequalities, and long-term projections concerning liver cancer mortality attributable to nonalcoholic steatohepatitis between 1990 and 2050.
Article in iLIVER, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and aims: Nonalcoholic steatohepatitis is an important and increasing contributor to liver cancer. This study investigated mortality trends in liver cancer attributable to nonalcoholic steatohepatitis (LCN) over recent decades and projected to 2050. Methods: Spatiotemporal trends in age-standardized mortality rates (ASMRs) for LCN were evaluated using a Bayesian model. The Bayesian Age-Period-Cohort model was used to predict the ASMR and mortality in 2022-2050. Temporal trends were analyzed by calculating the average annual percent change (AAPC) in ASMRs. Health inequalities, frontier analysis, and decomposition analysis were applied. Results: Between 1990 and 2021, the ASMR for LCN trended upwards worldwide (AAPC 0.82). The Americas had the most rapid growth in ASMR for LCN (AAPC 2.03), whereas the African region had the highest ASMR for LCN. By 2050, India (ASMR 0.76) and Indonesia (ASMR 0.50) are predicted to be among the most populous countries facing the highest ASMR burden. Health inequalities associated with a lower sociodemographic index value have worsened over time: the concentration index was -0.24 in 2021, and the slope index of inequality is projected to decline sharply from -0.33 in 2021 to -0.82 by 2050. Decomposition analysis showed that the increase in LCN mortality was mainly attributable to changes in epidemiology and age structure. The mortality burden of smoking and high fasting plasma glucose-related LCN has continued to rise over the last three decades. Conclusion: Global LCN mortality is escalating, particularly in low-sociodemographic and low-income regions. The expanding mortality burden associated with smoking and high fasting plasma glucose underscores the importance of lifestyle and metabolic risk factors in shaping future trajectories and the need for targeted prevention strategies in high-burden regions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.